Global Neurological Disorder Drugs Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Neurological Disorder Drugs market size was valued at US$ 1918.7 million in 2023. With growing demand in downstream market, the Neurological Disorder Drugs is forecast to a readjusted size of US$ 3513.2 million by 2030 with a CAGR of 9.0% during review period.
The research report highlights the growth potential of the global Neurological Disorder Drugs market. Neurological Disorder Drugs are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Neurological Disorder Drugs. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Neurological Disorder Drugs market.
Several government initiatives across various countries to educate masses about the rise of various diseases and increasing healthcare sector producing new drugs are the prime reasons for growth of neurological disorder drugs market. European Parkinson’s Disease Association, in Europe is actively supporting research and development by campaigning to raise awareness, and providing medication to patients is boosting the overall neurological disorder drugs market. This region is also witnessing rising focus on research and development programs that will help in producing affordable and effective drugs. The countries are collectively spending on developing neurological disorder drugs thus, improving the revenue of the market during the forecast period.
Staggering increase in brain altering disorders such as Alzheimer’s, epilepsy, Parkinson’s, cerebrovascular, and sclerosis are promoting the pharmaceutical firms to tap into the significantly growing neurological disorder drugs market. This will potentially supplement the market growth in the coming years. Rise of several innovative drugs to manage these diseases will swell up the investments in the market. Increasing number of clinical trials are another reason boosting the market. Rise in geriatric population along with patients with strokes, migraines, and headaches leading to cerebrovascular diseases are likely to augment the growth of the market.
Key Features:
The report on Neurological Disorder Drugs market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Neurological Disorder Drugs market. It may include historical data, market segmentation by Type (e.g., Antipsychotic, Hypnotic & Sedative), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Neurological Disorder Drugs market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Neurological Disorder Drugs market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Neurological Disorder Drugs industry. This include advancements in Neurological Disorder Drugs technology, Neurological Disorder Drugs new entrants, Neurological Disorder Drugs new investment, and other innovations that are shaping the future of Neurological Disorder Drugs.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Neurological Disorder Drugs market. It includes factors influencing customer ' purchasing decisions, preferences for Neurological Disorder Drugs product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Neurological Disorder Drugs market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Neurological Disorder Drugs market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Neurological Disorder Drugs market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Neurological Disorder Drugs industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Neurological Disorder Drugs market.
Market Segmentation:
Neurological Disorder Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Neurological Disorder Drugs market size was valued at US$ 1918.7 million in 2023. With growing demand in downstream market, the Neurological Disorder Drugs is forecast to a readjusted size of US$ 3513.2 million by 2030 with a CAGR of 9.0% during review period.
The research report highlights the growth potential of the global Neurological Disorder Drugs market. Neurological Disorder Drugs are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Neurological Disorder Drugs. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Neurological Disorder Drugs market.
Several government initiatives across various countries to educate masses about the rise of various diseases and increasing healthcare sector producing new drugs are the prime reasons for growth of neurological disorder drugs market. European Parkinson’s Disease Association, in Europe is actively supporting research and development by campaigning to raise awareness, and providing medication to patients is boosting the overall neurological disorder drugs market. This region is also witnessing rising focus on research and development programs that will help in producing affordable and effective drugs. The countries are collectively spending on developing neurological disorder drugs thus, improving the revenue of the market during the forecast period.
Staggering increase in brain altering disorders such as Alzheimer’s, epilepsy, Parkinson’s, cerebrovascular, and sclerosis are promoting the pharmaceutical firms to tap into the significantly growing neurological disorder drugs market. This will potentially supplement the market growth in the coming years. Rise of several innovative drugs to manage these diseases will swell up the investments in the market. Increasing number of clinical trials are another reason boosting the market. Rise in geriatric population along with patients with strokes, migraines, and headaches leading to cerebrovascular diseases are likely to augment the growth of the market.
Key Features:
The report on Neurological Disorder Drugs market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Neurological Disorder Drugs market. It may include historical data, market segmentation by Type (e.g., Antipsychotic, Hypnotic & Sedative), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Neurological Disorder Drugs market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Neurological Disorder Drugs market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Neurological Disorder Drugs industry. This include advancements in Neurological Disorder Drugs technology, Neurological Disorder Drugs new entrants, Neurological Disorder Drugs new investment, and other innovations that are shaping the future of Neurological Disorder Drugs.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Neurological Disorder Drugs market. It includes factors influencing customer ' purchasing decisions, preferences for Neurological Disorder Drugs product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Neurological Disorder Drugs market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Neurological Disorder Drugs market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Neurological Disorder Drugs market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Neurological Disorder Drugs industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Neurological Disorder Drugs market.
Market Segmentation:
Neurological Disorder Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Antipsychotic
- Hypnotic & Sedative
- Analgesics
- Anticoagulants
- Others
- Hospital
- Clinic
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Novartis
- GlaxoSmithKline
- Merck & Co.
- Bayer
- AstraZeneca
- Boehringer Ingelheim
- Teva Pharmaceutical
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Neurological Disorder Drugs Market Size 2019-2030
2.1.2 Neurological Disorder Drugs Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Neurological Disorder Drugs Segment by Type
2.2.1 Antipsychotic
2.2.2 Hypnotic & Sedative
2.2.3 Analgesics
2.2.4 Anticoagulants
2.2.5 Others
2.3 Neurological Disorder Drugs Market Size by Type
2.3.1 Neurological Disorder Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Neurological Disorder Drugs Market Size Market Share by Type (2019-2024)
2.4 Neurological Disorder Drugs Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 Neurological Disorder Drugs Market Size by Application
2.5.1 Neurological Disorder Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Neurological Disorder Drugs Market Size Market Share by Application (2019-2024)
3 NEUROLOGICAL DISORDER DRUGS MARKET SIZE BY PLAYER
3.1 Neurological Disorder Drugs Market Size Market Share by Players
3.1.1 Global Neurological Disorder Drugs Revenue by Players (2019-2024)
3.1.2 Global Neurological Disorder Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Neurological Disorder Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NEUROLOGICAL DISORDER DRUGS BY REGIONS
4.1 Neurological Disorder Drugs Market Size by Regions (2019-2024)
4.2 Americas Neurological Disorder Drugs Market Size Growth (2019-2024)
4.3 APAC Neurological Disorder Drugs Market Size Growth (2019-2024)
4.4 Europe Neurological Disorder Drugs Market Size Growth (2019-2024)
4.5 Middle East & Africa Neurological Disorder Drugs Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Neurological Disorder Drugs Market Size by Country (2019-2024)
5.2 Americas Neurological Disorder Drugs Market Size by Type (2019-2024)
5.3 Americas Neurological Disorder Drugs Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neurological Disorder Drugs Market Size by Region (2019-2024)
6.2 APAC Neurological Disorder Drugs Market Size by Type (2019-2024)
6.3 APAC Neurological Disorder Drugs Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Neurological Disorder Drugs by Country (2019-2024)
7.2 Europe Neurological Disorder Drugs Market Size by Type (2019-2024)
7.3 Europe Neurological Disorder Drugs Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Neurological Disorder Drugs by Region (2019-2024)
8.2 Middle East & Africa Neurological Disorder Drugs Market Size by Type (2019-2024)
8.3 Middle East & Africa Neurological Disorder Drugs Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NEUROLOGICAL DISORDER DRUGS MARKET FORECAST
10.1 Global Neurological Disorder Drugs Forecast by Regions (2025-2030)
10.1.1 Global Neurological Disorder Drugs Forecast by Regions (2025-2030)
10.1.2 Americas Neurological Disorder Drugs Forecast
10.1.3 APAC Neurological Disorder Drugs Forecast
10.1.4 Europe Neurological Disorder Drugs Forecast
10.1.5 Middle East & Africa Neurological Disorder Drugs Forecast
10.2 Americas Neurological Disorder Drugs Forecast by Country (2025-2030)
10.2.1 United States Neurological Disorder Drugs Market Forecast
10.2.2 Canada Neurological Disorder Drugs Market Forecast
10.2.3 Mexico Neurological Disorder Drugs Market Forecast
10.2.4 Brazil Neurological Disorder Drugs Market Forecast
10.3 APAC Neurological Disorder Drugs Forecast by Region (2025-2030)
10.3.1 China Neurological Disorder Drugs Market Forecast
10.3.2 Japan Neurological Disorder Drugs Market Forecast
10.3.3 Korea Neurological Disorder Drugs Market Forecast
10.3.4 Southeast Asia Neurological Disorder Drugs Market Forecast
10.3.5 India Neurological Disorder Drugs Market Forecast
10.3.6 Australia Neurological Disorder Drugs Market Forecast
10.4 Europe Neurological Disorder Drugs Forecast by Country (2025-2030)
10.4.1 Germany Neurological Disorder Drugs Market Forecast
10.4.2 France Neurological Disorder Drugs Market Forecast
10.4.3 UK Neurological Disorder Drugs Market Forecast
10.4.4 Italy Neurological Disorder Drugs Market Forecast
10.4.5 Russia Neurological Disorder Drugs Market Forecast
10.5 Middle East & Africa Neurological Disorder Drugs Forecast by Region (2025-2030)
10.5.1 Egypt Neurological Disorder Drugs Market Forecast
10.5.2 South Africa Neurological Disorder Drugs Market Forecast
10.5.3 Israel Neurological Disorder Drugs Market Forecast
10.5.4 Turkey Neurological Disorder Drugs Market Forecast
10.5.5 GCC Countries Neurological Disorder Drugs Market Forecast
10.6 Global Neurological Disorder Drugs Forecast by Type (2025-2030)
10.7 Global Neurological Disorder Drugs Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Novartis
11.1.1 Novartis Company Information
11.1.2 Novartis Neurological Disorder Drugs Product Offered
11.1.3 Novartis Neurological Disorder Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Novartis Main Business Overview
11.1.5 Novartis Latest Developments
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Information
11.2.2 GlaxoSmithKline Neurological Disorder Drugs Product Offered
11.2.3 GlaxoSmithKline Neurological Disorder Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 GlaxoSmithKline Main Business Overview
11.2.5 GlaxoSmithKline Latest Developments
11.3 Merck & Co.
11.3.1 Merck & Co. Company Information
11.3.2 Merck & Co. Neurological Disorder Drugs Product Offered
11.3.3 Merck & Co. Neurological Disorder Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Merck & Co. Main Business Overview
11.3.5 Merck & Co. Latest Developments
11.4 Bayer
11.4.1 Bayer Company Information
11.4.2 Bayer Neurological Disorder Drugs Product Offered
11.4.3 Bayer Neurological Disorder Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Bayer Main Business Overview
11.4.5 Bayer Latest Developments
11.5 AstraZeneca
11.5.1 AstraZeneca Company Information
11.5.2 AstraZeneca Neurological Disorder Drugs Product Offered
11.5.3 AstraZeneca Neurological Disorder Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 AstraZeneca Main Business Overview
11.5.5 AstraZeneca Latest Developments
11.6 Boehringer Ingelheim
11.6.1 Boehringer Ingelheim Company Information
11.6.2 Boehringer Ingelheim Neurological Disorder Drugs Product Offered
11.6.3 Boehringer Ingelheim Neurological Disorder Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Boehringer Ingelheim Main Business Overview
11.6.5 Boehringer Ingelheim Latest Developments
11.7 Teva Pharmaceutical
11.7.1 Teva Pharmaceutical Company Information
11.7.2 Teva Pharmaceutical Neurological Disorder Drugs Product Offered
11.7.3 Teva Pharmaceutical Neurological Disorder Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Teva Pharmaceutical Main Business Overview
11.7.5 Teva Pharmaceutical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Neurological Disorder Drugs Market Size 2019-2030
2.1.2 Neurological Disorder Drugs Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Neurological Disorder Drugs Segment by Type
2.2.1 Antipsychotic
2.2.2 Hypnotic & Sedative
2.2.3 Analgesics
2.2.4 Anticoagulants
2.2.5 Others
2.3 Neurological Disorder Drugs Market Size by Type
2.3.1 Neurological Disorder Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Neurological Disorder Drugs Market Size Market Share by Type (2019-2024)
2.4 Neurological Disorder Drugs Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 Neurological Disorder Drugs Market Size by Application
2.5.1 Neurological Disorder Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Neurological Disorder Drugs Market Size Market Share by Application (2019-2024)
3 NEUROLOGICAL DISORDER DRUGS MARKET SIZE BY PLAYER
3.1 Neurological Disorder Drugs Market Size Market Share by Players
3.1.1 Global Neurological Disorder Drugs Revenue by Players (2019-2024)
3.1.2 Global Neurological Disorder Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Neurological Disorder Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NEUROLOGICAL DISORDER DRUGS BY REGIONS
4.1 Neurological Disorder Drugs Market Size by Regions (2019-2024)
4.2 Americas Neurological Disorder Drugs Market Size Growth (2019-2024)
4.3 APAC Neurological Disorder Drugs Market Size Growth (2019-2024)
4.4 Europe Neurological Disorder Drugs Market Size Growth (2019-2024)
4.5 Middle East & Africa Neurological Disorder Drugs Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Neurological Disorder Drugs Market Size by Country (2019-2024)
5.2 Americas Neurological Disorder Drugs Market Size by Type (2019-2024)
5.3 Americas Neurological Disorder Drugs Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neurological Disorder Drugs Market Size by Region (2019-2024)
6.2 APAC Neurological Disorder Drugs Market Size by Type (2019-2024)
6.3 APAC Neurological Disorder Drugs Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Neurological Disorder Drugs by Country (2019-2024)
7.2 Europe Neurological Disorder Drugs Market Size by Type (2019-2024)
7.3 Europe Neurological Disorder Drugs Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Neurological Disorder Drugs by Region (2019-2024)
8.2 Middle East & Africa Neurological Disorder Drugs Market Size by Type (2019-2024)
8.3 Middle East & Africa Neurological Disorder Drugs Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NEUROLOGICAL DISORDER DRUGS MARKET FORECAST
10.1 Global Neurological Disorder Drugs Forecast by Regions (2025-2030)
10.1.1 Global Neurological Disorder Drugs Forecast by Regions (2025-2030)
10.1.2 Americas Neurological Disorder Drugs Forecast
10.1.3 APAC Neurological Disorder Drugs Forecast
10.1.4 Europe Neurological Disorder Drugs Forecast
10.1.5 Middle East & Africa Neurological Disorder Drugs Forecast
10.2 Americas Neurological Disorder Drugs Forecast by Country (2025-2030)
10.2.1 United States Neurological Disorder Drugs Market Forecast
10.2.2 Canada Neurological Disorder Drugs Market Forecast
10.2.3 Mexico Neurological Disorder Drugs Market Forecast
10.2.4 Brazil Neurological Disorder Drugs Market Forecast
10.3 APAC Neurological Disorder Drugs Forecast by Region (2025-2030)
10.3.1 China Neurological Disorder Drugs Market Forecast
10.3.2 Japan Neurological Disorder Drugs Market Forecast
10.3.3 Korea Neurological Disorder Drugs Market Forecast
10.3.4 Southeast Asia Neurological Disorder Drugs Market Forecast
10.3.5 India Neurological Disorder Drugs Market Forecast
10.3.6 Australia Neurological Disorder Drugs Market Forecast
10.4 Europe Neurological Disorder Drugs Forecast by Country (2025-2030)
10.4.1 Germany Neurological Disorder Drugs Market Forecast
10.4.2 France Neurological Disorder Drugs Market Forecast
10.4.3 UK Neurological Disorder Drugs Market Forecast
10.4.4 Italy Neurological Disorder Drugs Market Forecast
10.4.5 Russia Neurological Disorder Drugs Market Forecast
10.5 Middle East & Africa Neurological Disorder Drugs Forecast by Region (2025-2030)
10.5.1 Egypt Neurological Disorder Drugs Market Forecast
10.5.2 South Africa Neurological Disorder Drugs Market Forecast
10.5.3 Israel Neurological Disorder Drugs Market Forecast
10.5.4 Turkey Neurological Disorder Drugs Market Forecast
10.5.5 GCC Countries Neurological Disorder Drugs Market Forecast
10.6 Global Neurological Disorder Drugs Forecast by Type (2025-2030)
10.7 Global Neurological Disorder Drugs Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Novartis
11.1.1 Novartis Company Information
11.1.2 Novartis Neurological Disorder Drugs Product Offered
11.1.3 Novartis Neurological Disorder Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Novartis Main Business Overview
11.1.5 Novartis Latest Developments
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Information
11.2.2 GlaxoSmithKline Neurological Disorder Drugs Product Offered
11.2.3 GlaxoSmithKline Neurological Disorder Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 GlaxoSmithKline Main Business Overview
11.2.5 GlaxoSmithKline Latest Developments
11.3 Merck & Co.
11.3.1 Merck & Co. Company Information
11.3.2 Merck & Co. Neurological Disorder Drugs Product Offered
11.3.3 Merck & Co. Neurological Disorder Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Merck & Co. Main Business Overview
11.3.5 Merck & Co. Latest Developments
11.4 Bayer
11.4.1 Bayer Company Information
11.4.2 Bayer Neurological Disorder Drugs Product Offered
11.4.3 Bayer Neurological Disorder Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Bayer Main Business Overview
11.4.5 Bayer Latest Developments
11.5 AstraZeneca
11.5.1 AstraZeneca Company Information
11.5.2 AstraZeneca Neurological Disorder Drugs Product Offered
11.5.3 AstraZeneca Neurological Disorder Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 AstraZeneca Main Business Overview
11.5.5 AstraZeneca Latest Developments
11.6 Boehringer Ingelheim
11.6.1 Boehringer Ingelheim Company Information
11.6.2 Boehringer Ingelheim Neurological Disorder Drugs Product Offered
11.6.3 Boehringer Ingelheim Neurological Disorder Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Boehringer Ingelheim Main Business Overview
11.6.5 Boehringer Ingelheim Latest Developments
11.7 Teva Pharmaceutical
11.7.1 Teva Pharmaceutical Company Information
11.7.2 Teva Pharmaceutical Neurological Disorder Drugs Product Offered
11.7.3 Teva Pharmaceutical Neurological Disorder Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Teva Pharmaceutical Main Business Overview
11.7.5 Teva Pharmaceutical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Neurological Disorder Drugs Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Antipsychotic
Table 3. Major Players of Hypnotic & Sedative
Table 4. Major Players of Analgesics
Table 5. Major Players of Anticoagulants
Table 6. Major Players of Others
Table 7. Neurological Disorder Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Neurological Disorder Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 9. Global Neurological Disorder Drugs Market Size Market Share by Type (2019-2024)
Table 10. Neurological Disorder Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 11. Global Neurological Disorder Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 12. Global Neurological Disorder Drugs Market Size Market Share by Application (2019-2024)
Table 13. Global Neurological Disorder Drugs Revenue by Players (2019-2024) & ($ Millions)
Table 14. Global Neurological Disorder Drugs Revenue Market Share by Player (2019-2024)
Table 15. Neurological Disorder Drugs Key Players Head office and Products Offered
Table 16. Neurological Disorder Drugs Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Neurological Disorder Drugs Market Size by Regions 2019-2024 & ($ Millions)
Table 20. Global Neurological Disorder Drugs Market Size Market Share by Regions (2019-2024)
Table 21. Global Neurological Disorder Drugs Revenue by Country/Region (2019-2024) & ($ millions)
Table 22. Global Neurological Disorder Drugs Revenue Market Share by Country/Region (2019-2024)
Table 23. Americas Neurological Disorder Drugs Market Size by Country (2019-2024) & ($ Millions)
Table 24. Americas Neurological Disorder Drugs Market Size Market Share by Country (2019-2024)
Table 25. Americas Neurological Disorder Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 26. Americas Neurological Disorder Drugs Market Size Market Share by Type (2019-2024)
Table 27. Americas Neurological Disorder Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 28. Americas Neurological Disorder Drugs Market Size Market Share by Application (2019-2024)
Table 29. APAC Neurological Disorder Drugs Market Size by Region (2019-2024) & ($ Millions)
Table 30. APAC Neurological Disorder Drugs Market Size Market Share by Region (2019-2024)
Table 31. APAC Neurological Disorder Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 32. APAC Neurological Disorder Drugs Market Size Market Share by Type (2019-2024)
Table 33. APAC Neurological Disorder Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 34. APAC Neurological Disorder Drugs Market Size Market Share by Application (2019-2024)
Table 35. Europe Neurological Disorder Drugs Market Size by Country (2019-2024) & ($ Millions)
Table 36. Europe Neurological Disorder Drugs Market Size Market Share by Country (2019-2024)
Table 37. Europe Neurological Disorder Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 38. Europe Neurological Disorder Drugs Market Size Market Share by Type (2019-2024)
Table 39. Europe Neurological Disorder Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 40. Europe Neurological Disorder Drugs Market Size Market Share by Application (2019-2024)
Table 41. Middle East & Africa Neurological Disorder Drugs Market Size by Region (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Neurological Disorder Drugs Market Size Market Share by Region (2019-2024)
Table 43. Middle East & Africa Neurological Disorder Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Neurological Disorder Drugs Market Size Market Share by Type (2019-2024)
Table 45. Middle East & Africa Neurological Disorder Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 46. Middle East & Africa Neurological Disorder Drugs Market Size Market Share by Application (2019-2024)
Table 47. Key Market Drivers & Growth Opportunities of Neurological Disorder Drugs
Table 48. Key Market Challenges & Risks of Neurological Disorder Drugs
Table 49. Key Industry Trends of Neurological Disorder Drugs
Table 50. Global Neurological Disorder Drugs Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 51. Global Neurological Disorder Drugs Market Size Market Share Forecast by Regions (2025-2030)
Table 52. Global Neurological Disorder Drugs Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 53. Global Neurological Disorder Drugs Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 54. Novartis Details, Company Type, Neurological Disorder Drugs Area Served and Its Competitors
Table 55. Novartis Neurological Disorder Drugs Product Offered
Table 56. Novartis Neurological Disorder Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 57. Novartis Main Business
Table 58. Novartis Latest Developments
Table 59. GlaxoSmithKline Details, Company Type, Neurological Disorder Drugs Area Served and Its Competitors
Table 60. GlaxoSmithKline Neurological Disorder Drugs Product Offered
Table 61. GlaxoSmithKline Main Business
Table 62. GlaxoSmithKline Neurological Disorder Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 63. GlaxoSmithKline Latest Developments
Table 64. Merck & Co. Details, Company Type, Neurological Disorder Drugs Area Served and Its Competitors
Table 65. Merck & Co. Neurological Disorder Drugs Product Offered
Table 66. Merck & Co. Main Business
Table 67. Merck & Co. Neurological Disorder Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 68. Merck & Co. Latest Developments
Table 69. Bayer Details, Company Type, Neurological Disorder Drugs Area Served and Its Competitors
Table 70. Bayer Neurological Disorder Drugs Product Offered
Table 71. Bayer Main Business
Table 72. Bayer Neurological Disorder Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 73. Bayer Latest Developments
Table 74. AstraZeneca Details, Company Type, Neurological Disorder Drugs Area Served and Its Competitors
Table 75. AstraZeneca Neurological Disorder Drugs Product Offered
Table 76. AstraZeneca Main Business
Table 77. AstraZeneca Neurological Disorder Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 78. AstraZeneca Latest Developments
Table 79. Boehringer Ingelheim Details, Company Type, Neurological Disorder Drugs Area Served and Its Competitors
Table 80. Boehringer Ingelheim Neurological Disorder Drugs Product Offered
Table 81. Boehringer Ingelheim Main Business
Table 82. Boehringer Ingelheim Neurological Disorder Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 83. Boehringer Ingelheim Latest Developments
Table 84. Teva Pharmaceutical Details, Company Type, Neurological Disorder Drugs Area Served and Its Competitors
Table 85. Teva Pharmaceutical Neurological Disorder Drugs Product Offered
Table 86. Teva Pharmaceutical Main Business
Table 87. Teva Pharmaceutical Neurological Disorder Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 88. Teva Pharmaceutical Latest Developments
Table 1. Neurological Disorder Drugs Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Antipsychotic
Table 3. Major Players of Hypnotic & Sedative
Table 4. Major Players of Analgesics
Table 5. Major Players of Anticoagulants
Table 6. Major Players of Others
Table 7. Neurological Disorder Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Neurological Disorder Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 9. Global Neurological Disorder Drugs Market Size Market Share by Type (2019-2024)
Table 10. Neurological Disorder Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 11. Global Neurological Disorder Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 12. Global Neurological Disorder Drugs Market Size Market Share by Application (2019-2024)
Table 13. Global Neurological Disorder Drugs Revenue by Players (2019-2024) & ($ Millions)
Table 14. Global Neurological Disorder Drugs Revenue Market Share by Player (2019-2024)
Table 15. Neurological Disorder Drugs Key Players Head office and Products Offered
Table 16. Neurological Disorder Drugs Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Neurological Disorder Drugs Market Size by Regions 2019-2024 & ($ Millions)
Table 20. Global Neurological Disorder Drugs Market Size Market Share by Regions (2019-2024)
Table 21. Global Neurological Disorder Drugs Revenue by Country/Region (2019-2024) & ($ millions)
Table 22. Global Neurological Disorder Drugs Revenue Market Share by Country/Region (2019-2024)
Table 23. Americas Neurological Disorder Drugs Market Size by Country (2019-2024) & ($ Millions)
Table 24. Americas Neurological Disorder Drugs Market Size Market Share by Country (2019-2024)
Table 25. Americas Neurological Disorder Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 26. Americas Neurological Disorder Drugs Market Size Market Share by Type (2019-2024)
Table 27. Americas Neurological Disorder Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 28. Americas Neurological Disorder Drugs Market Size Market Share by Application (2019-2024)
Table 29. APAC Neurological Disorder Drugs Market Size by Region (2019-2024) & ($ Millions)
Table 30. APAC Neurological Disorder Drugs Market Size Market Share by Region (2019-2024)
Table 31. APAC Neurological Disorder Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 32. APAC Neurological Disorder Drugs Market Size Market Share by Type (2019-2024)
Table 33. APAC Neurological Disorder Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 34. APAC Neurological Disorder Drugs Market Size Market Share by Application (2019-2024)
Table 35. Europe Neurological Disorder Drugs Market Size by Country (2019-2024) & ($ Millions)
Table 36. Europe Neurological Disorder Drugs Market Size Market Share by Country (2019-2024)
Table 37. Europe Neurological Disorder Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 38. Europe Neurological Disorder Drugs Market Size Market Share by Type (2019-2024)
Table 39. Europe Neurological Disorder Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 40. Europe Neurological Disorder Drugs Market Size Market Share by Application (2019-2024)
Table 41. Middle East & Africa Neurological Disorder Drugs Market Size by Region (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Neurological Disorder Drugs Market Size Market Share by Region (2019-2024)
Table 43. Middle East & Africa Neurological Disorder Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Neurological Disorder Drugs Market Size Market Share by Type (2019-2024)
Table 45. Middle East & Africa Neurological Disorder Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 46. Middle East & Africa Neurological Disorder Drugs Market Size Market Share by Application (2019-2024)
Table 47. Key Market Drivers & Growth Opportunities of Neurological Disorder Drugs
Table 48. Key Market Challenges & Risks of Neurological Disorder Drugs
Table 49. Key Industry Trends of Neurological Disorder Drugs
Table 50. Global Neurological Disorder Drugs Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 51. Global Neurological Disorder Drugs Market Size Market Share Forecast by Regions (2025-2030)
Table 52. Global Neurological Disorder Drugs Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 53. Global Neurological Disorder Drugs Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 54. Novartis Details, Company Type, Neurological Disorder Drugs Area Served and Its Competitors
Table 55. Novartis Neurological Disorder Drugs Product Offered
Table 56. Novartis Neurological Disorder Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 57. Novartis Main Business
Table 58. Novartis Latest Developments
Table 59. GlaxoSmithKline Details, Company Type, Neurological Disorder Drugs Area Served and Its Competitors
Table 60. GlaxoSmithKline Neurological Disorder Drugs Product Offered
Table 61. GlaxoSmithKline Main Business
Table 62. GlaxoSmithKline Neurological Disorder Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 63. GlaxoSmithKline Latest Developments
Table 64. Merck & Co. Details, Company Type, Neurological Disorder Drugs Area Served and Its Competitors
Table 65. Merck & Co. Neurological Disorder Drugs Product Offered
Table 66. Merck & Co. Main Business
Table 67. Merck & Co. Neurological Disorder Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 68. Merck & Co. Latest Developments
Table 69. Bayer Details, Company Type, Neurological Disorder Drugs Area Served and Its Competitors
Table 70. Bayer Neurological Disorder Drugs Product Offered
Table 71. Bayer Main Business
Table 72. Bayer Neurological Disorder Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 73. Bayer Latest Developments
Table 74. AstraZeneca Details, Company Type, Neurological Disorder Drugs Area Served and Its Competitors
Table 75. AstraZeneca Neurological Disorder Drugs Product Offered
Table 76. AstraZeneca Main Business
Table 77. AstraZeneca Neurological Disorder Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 78. AstraZeneca Latest Developments
Table 79. Boehringer Ingelheim Details, Company Type, Neurological Disorder Drugs Area Served and Its Competitors
Table 80. Boehringer Ingelheim Neurological Disorder Drugs Product Offered
Table 81. Boehringer Ingelheim Main Business
Table 82. Boehringer Ingelheim Neurological Disorder Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 83. Boehringer Ingelheim Latest Developments
Table 84. Teva Pharmaceutical Details, Company Type, Neurological Disorder Drugs Area Served and Its Competitors
Table 85. Teva Pharmaceutical Neurological Disorder Drugs Product Offered
Table 86. Teva Pharmaceutical Main Business
Table 87. Teva Pharmaceutical Neurological Disorder Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 88. Teva Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Neurological Disorder Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Neurological Disorder Drugs Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Neurological Disorder Drugs Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Neurological Disorder Drugs Sales Market Share by Country/Region (2023)
Figure 8. Neurological Disorder Drugs Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Neurological Disorder Drugs Market Size Market Share by Type in 2023
Figure 10. Neurological Disorder Drugs in Hospital
Figure 11. Global Neurological Disorder Drugs Market: Hospital (2019-2024) & ($ Millions)
Figure 12. Neurological Disorder Drugs in Clinic
Figure 13. Global Neurological Disorder Drugs Market: Clinic (2019-2024) & ($ Millions)
Figure 14. Global Neurological Disorder Drugs Market Size Market Share by Application in 2023
Figure 15. Global Neurological Disorder Drugs Revenue Market Share by Player in 2023
Figure 16. Global Neurological Disorder Drugs Market Size Market Share by Regions (2019-2024)
Figure 17. Americas Neurological Disorder Drugs Market Size 2019-2024 ($ Millions)
Figure 18. APAC Neurological Disorder Drugs Market Size 2019-2024 ($ Millions)
Figure 19. Europe Neurological Disorder Drugs Market Size 2019-2024 ($ Millions)
Figure 20. Middle East & Africa Neurological Disorder Drugs Market Size 2019-2024 ($ Millions)
Figure 21. Americas Neurological Disorder Drugs Value Market Share by Country in 2023
Figure 22. United States Neurological Disorder Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 23. Canada Neurological Disorder Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 24. Mexico Neurological Disorder Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 25. Brazil Neurological Disorder Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 26. APAC Neurological Disorder Drugs Market Size Market Share by Region in 2023
Figure 27. APAC Neurological Disorder Drugs Market Size Market Share by Type in 2023
Figure 28. APAC Neurological Disorder Drugs Market Size Market Share by Application in 2023
Figure 29. China Neurological Disorder Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 30. Japan Neurological Disorder Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 31. Korea Neurological Disorder Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 32. Southeast Asia Neurological Disorder Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 33. India Neurological Disorder Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 34. Australia Neurological Disorder Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 35. Europe Neurological Disorder Drugs Market Size Market Share by Country in 2023
Figure 36. Europe Neurological Disorder Drugs Market Size Market Share by Type (2019-2024)
Figure 37. Europe Neurological Disorder Drugs Market Size Market Share by Application (2019-2024)
Figure 38. Germany Neurological Disorder Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 39. France Neurological Disorder Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 40. UK Neurological Disorder Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 41. Italy Neurological Disorder Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 42. Russia Neurological Disorder Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 43. Middle East & Africa Neurological Disorder Drugs Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Neurological Disorder Drugs Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Neurological Disorder Drugs Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Neurological Disorder Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 47. South Africa Neurological Disorder Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 48. Israel Neurological Disorder Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 49. Turkey Neurological Disorder Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 50. GCC Country Neurological Disorder Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 51. Americas Neurological Disorder Drugs Market Size 2025-2030 ($ Millions)
Figure 52. APAC Neurological Disorder Drugs Market Size 2025-2030 ($ Millions)
Figure 53. Europe Neurological Disorder Drugs Market Size 2025-2030 ($ Millions)
Figure 54. Middle East & Africa Neurological Disorder Drugs Market Size 2025-2030 ($ Millions)
Figure 55. United States Neurological Disorder Drugs Market Size 2025-2030 ($ Millions)
Figure 56. Canada Neurological Disorder Drugs Market Size 2025-2030 ($ Millions)
Figure 57. Mexico Neurological Disorder Drugs Market Size 2025-2030 ($ Millions)
Figure 58. Brazil Neurological Disorder Drugs Market Size 2025-2030 ($ Millions)
Figure 59. China Neurological Disorder Drugs Market Size 2025-2030 ($ Millions)
Figure 60. Japan Neurological Disorder Drugs Market Size 2025-2030 ($ Millions)
Figure 61. Korea Neurological Disorder Drugs Market Size 2025-2030 ($ Millions)
Figure 62. Southeast Asia Neurological Disorder Drugs Market Size 2025-2030 ($ Millions)
Figure 63. India Neurological Disorder Drugs Market Size 2025-2030 ($ Millions)
Figure 64. Australia Neurological Disorder Drugs Market Size 2025-2030 ($ Millions)
Figure 65. Germany Neurological Disorder Drugs Market Size 2025-2030 ($ Millions)
Figure 66. France Neurological Disorder Drugs Market Size 2025-2030 ($ Millions)
Figure 67. UK Neurological Disorder Drugs Market Size 2025-2030 ($ Millions)
Figure 68. Italy Neurological Disorder Drugs Market Size 2025-2030 ($ Millions)
Figure 69. Russia Neurological Disorder Drugs Market Size 2025-2030 ($ Millions)
Figure 70. Spain Neurological Disorder Drugs Market Size 2025-2030 ($ Millions)
Figure 71. Egypt Neurological Disorder Drugs Market Size 2025-2030 ($ Millions)
Figure 72. South Africa Neurological Disorder Drugs Market Size 2025-2030 ($ Millions)
Figure 73. Israel Neurological Disorder Drugs Market Size 2025-2030 ($ Millions)
Figure 74. Turkey Neurological Disorder Drugs Market Size 2025-2030 ($ Millions)
Figure 75. GCC Countries Neurological Disorder Drugs Market Size 2025-2030 ($ Millions)
Figure 76. Global Neurological Disorder Drugs Market Size Market Share Forecast by Type (2025-2030)
Figure 77. Global Neurological Disorder Drugs Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Neurological Disorder Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Neurological Disorder Drugs Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Neurological Disorder Drugs Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Neurological Disorder Drugs Sales Market Share by Country/Region (2023)
Figure 8. Neurological Disorder Drugs Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Neurological Disorder Drugs Market Size Market Share by Type in 2023
Figure 10. Neurological Disorder Drugs in Hospital
Figure 11. Global Neurological Disorder Drugs Market: Hospital (2019-2024) & ($ Millions)
Figure 12. Neurological Disorder Drugs in Clinic
Figure 13. Global Neurological Disorder Drugs Market: Clinic (2019-2024) & ($ Millions)
Figure 14. Global Neurological Disorder Drugs Market Size Market Share by Application in 2023
Figure 15. Global Neurological Disorder Drugs Revenue Market Share by Player in 2023
Figure 16. Global Neurological Disorder Drugs Market Size Market Share by Regions (2019-2024)
Figure 17. Americas Neurological Disorder Drugs Market Size 2019-2024 ($ Millions)
Figure 18. APAC Neurological Disorder Drugs Market Size 2019-2024 ($ Millions)
Figure 19. Europe Neurological Disorder Drugs Market Size 2019-2024 ($ Millions)
Figure 20. Middle East & Africa Neurological Disorder Drugs Market Size 2019-2024 ($ Millions)
Figure 21. Americas Neurological Disorder Drugs Value Market Share by Country in 2023
Figure 22. United States Neurological Disorder Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 23. Canada Neurological Disorder Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 24. Mexico Neurological Disorder Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 25. Brazil Neurological Disorder Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 26. APAC Neurological Disorder Drugs Market Size Market Share by Region in 2023
Figure 27. APAC Neurological Disorder Drugs Market Size Market Share by Type in 2023
Figure 28. APAC Neurological Disorder Drugs Market Size Market Share by Application in 2023
Figure 29. China Neurological Disorder Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 30. Japan Neurological Disorder Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 31. Korea Neurological Disorder Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 32. Southeast Asia Neurological Disorder Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 33. India Neurological Disorder Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 34. Australia Neurological Disorder Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 35. Europe Neurological Disorder Drugs Market Size Market Share by Country in 2023
Figure 36. Europe Neurological Disorder Drugs Market Size Market Share by Type (2019-2024)
Figure 37. Europe Neurological Disorder Drugs Market Size Market Share by Application (2019-2024)
Figure 38. Germany Neurological Disorder Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 39. France Neurological Disorder Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 40. UK Neurological Disorder Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 41. Italy Neurological Disorder Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 42. Russia Neurological Disorder Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 43. Middle East & Africa Neurological Disorder Drugs Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Neurological Disorder Drugs Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Neurological Disorder Drugs Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Neurological Disorder Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 47. South Africa Neurological Disorder Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 48. Israel Neurological Disorder Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 49. Turkey Neurological Disorder Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 50. GCC Country Neurological Disorder Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 51. Americas Neurological Disorder Drugs Market Size 2025-2030 ($ Millions)
Figure 52. APAC Neurological Disorder Drugs Market Size 2025-2030 ($ Millions)
Figure 53. Europe Neurological Disorder Drugs Market Size 2025-2030 ($ Millions)
Figure 54. Middle East & Africa Neurological Disorder Drugs Market Size 2025-2030 ($ Millions)
Figure 55. United States Neurological Disorder Drugs Market Size 2025-2030 ($ Millions)
Figure 56. Canada Neurological Disorder Drugs Market Size 2025-2030 ($ Millions)
Figure 57. Mexico Neurological Disorder Drugs Market Size 2025-2030 ($ Millions)
Figure 58. Brazil Neurological Disorder Drugs Market Size 2025-2030 ($ Millions)
Figure 59. China Neurological Disorder Drugs Market Size 2025-2030 ($ Millions)
Figure 60. Japan Neurological Disorder Drugs Market Size 2025-2030 ($ Millions)
Figure 61. Korea Neurological Disorder Drugs Market Size 2025-2030 ($ Millions)
Figure 62. Southeast Asia Neurological Disorder Drugs Market Size 2025-2030 ($ Millions)
Figure 63. India Neurological Disorder Drugs Market Size 2025-2030 ($ Millions)
Figure 64. Australia Neurological Disorder Drugs Market Size 2025-2030 ($ Millions)
Figure 65. Germany Neurological Disorder Drugs Market Size 2025-2030 ($ Millions)
Figure 66. France Neurological Disorder Drugs Market Size 2025-2030 ($ Millions)
Figure 67. UK Neurological Disorder Drugs Market Size 2025-2030 ($ Millions)
Figure 68. Italy Neurological Disorder Drugs Market Size 2025-2030 ($ Millions)
Figure 69. Russia Neurological Disorder Drugs Market Size 2025-2030 ($ Millions)
Figure 70. Spain Neurological Disorder Drugs Market Size 2025-2030 ($ Millions)
Figure 71. Egypt Neurological Disorder Drugs Market Size 2025-2030 ($ Millions)
Figure 72. South Africa Neurological Disorder Drugs Market Size 2025-2030 ($ Millions)
Figure 73. Israel Neurological Disorder Drugs Market Size 2025-2030 ($ Millions)
Figure 74. Turkey Neurological Disorder Drugs Market Size 2025-2030 ($ Millions)
Figure 75. GCC Countries Neurological Disorder Drugs Market Size 2025-2030 ($ Millions)
Figure 76. Global Neurological Disorder Drugs Market Size Market Share Forecast by Type (2025-2030)
Figure 77. Global Neurological Disorder Drugs Market Size Market Share Forecast by Application (2025-2030)
